A database of FDA approved therapeutic peptides and proteins
ID1423 | ThPPIDTh1071 | NamePancrelipase | Peptide SequencePancreatic alpha amy Full view | Length1206 | Functional ClassificationIa | DiseaseMetabolic/genetic/ | BrandViokace | CompanyAptalis Pharma US, Inc. | Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble in alcohol and converted to tablet form | Route of AdministartionOral route | CategoryGastrointestinal Agents and Enzyme Replacement Agents | TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch |
ID1648 | ThPPIDTh1148 | NameAliskiren | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIa | DiseaseMetabolic | BrandTekturna | CompanyPhysicians Total Care, Inc. | Physical AppearanceLight-pink, biconvex round tablet | Route of AdministartionOral route | CategoryRenin inhibitor | TargetRenin |
ID1649 | ThPPIDTh1148 | NameAliskiren | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIa | DiseaseMetabolic | BrandTekturna | CompanyNovartis Pharmaceuticals Corporation | Physical AppearanceLight-pink, biconvex round tablet | Route of AdministartionOral route | CategoryRenin inhibitor | TargetRenin |
ID1650 | ThPPIDTh1148 | NameAliskiren | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIa | DiseaseMetabolic | BrandTekturna HCT | CompanyNovartis Pharmaceuticals Corporation | Physical AppearanceBiconvex, ovaloid film-coated tablets. | Route of AdministartionOral route | CategoryRenin inhibitor | TargetRenin |
ID1651 | ThPPIDTh1148 | NameAliskiren | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIa | DiseaseMetabolic | BrandTekamlo | CompanyNovartis Pharmaceuticals Corporation | Physical AppearanceTablets (aliskiren/amlodipine): 150 mg/5 mg, 150 mg/10 mg, 300 mg/5 mg, 300 mg/10 mg | Route of AdministartionOral route | CategoryRenin inhibitor | TargetRenin |
ID1652 | ThPPIDTh1148 | NameAliskiren | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIa | DiseaseMetabolic | BrandAmturnide | CompanyNovartis Pharmaceuticals Corporation | Physical AppearanceTablets (aliskiren/ amlodipine/ HCTZ): 150/5/12.5, 300/5/12.5, 300/5/25, 300/10/12.5, 300/10/25 mg. | Route of AdministartionOral route | CategoryRenin inhibitor | TargetRenin |
ID1653 | ThPPIDTh1149 | NameRagweed Pollen Extract | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIIa | DiseaseImmunological | BrandRagwitek | CompanyMerck Sharp & Dohme | Physical AppearanceTablets | Route of AdministartionOral route | CategoryN.A. | TargetN.A. |